Technicals — Down just 1.4% to $194.83 in a chip-sector bloodbath week — notably resilient. Price is hugging the 200-day at $191, the first genuine test of the long-term trendline in 2026. RSI 41 is soft but not oversold; the 20/50-day ($203/$210) cap upside. Its relative strength is the best signal in the sector this week.
Fundamentals — Revenue +70.7%, EPS +110%, yet the P/E sits at just 29.8 — sideways price action plus earnings catch-up has pushed the multiple to its cheapest percentile in a year. The worry is the second derivative: if hyperscaler capex peaks in 2026, 30x isn't cheap either. For now, order visibility still runs into 2027.
News — The week's key incremental positive: the strategic partnership with Palantir, putting its AI models into U.S. government and critical-infrastructure deployments — a revenue narrative that doesn't lean on hyperscaler capex. Sector-wide profit-taking pressure lingers, with Broadcom's guidance scare still echoing.
First 200-day retest, sector-leading relative strength, and the cheapest multiple in a year — the best odds on the board amid the panic. A break of $178 (one ATR below the 200-day) upgrades panic to trend reversal; take the loss and walk.
Pricing power in AI compute plus the CUDA moat remain unshaken, and 29.8x for 70% growth is a rare 'growth stock at a value multiple' window this cycle. Government and sovereign-AI orders are opening a second growth curve.
- Hyperscaler capex peaks or shifts to in-house ASICs
- Tighter export controls cutting off China and parts of Middle East demand
- AI monetization disappoints and the whole complex de-rates
- 07-04Long$194.83 → open → $194.83+0.00%
- WSB · Mentions fell from 168 to 39; the faithful stayed eerily quiet through the bloodbath — no panic is what real conviction looks likeOriginal ↗
- 华尔街共识 · 66 analysts, average target $313.4 (+61% vs. spot), rating 1.13 — firmly in strong-buy territory
- Palantir 合作 · Teaming with Palantir to deploy AI across U.S. government and critical infrastructure opens a non-hyperscaler revenue lineSource ↗